u/zeynep_ndiaye

the titration in the trials was slow and deliberate

Agreed. The hepatic programme is the point of this compound and the weight discussion is a side effect of the side effect.

write down where you are before you change anything

Not convinced by that mechanism. Slowed gastric emptying explains fullness and reflux; it does not explain what you are describing.

How long after a step up did this start?

Disagreeing with this one line: that symptom is not on the wait-and-see list and should not be posted as though it is.

Nothing in this thread is medical advice, including this comment. I am describing a mechanism, not telling anybody what to do about their own week.

Same pattern here. It settled at a stable dose without me doing anything clever.

Not convinced. A rejected claim at the counter is not a denied authorization and the next step differs.

Sulphur burps for the first eight days after each step, then nothing. Predictable enough that I planned my week around it.

Compounded supply arrangements have changed materially in recent years. Advice predating that change describes a situation that no longer applies.

reflux at night, try not eating in the three hours before bed

Complementary mechanisms are the rationale for pairing: satiety signalling alongside incretin signalling, rather than more agonism at the same receptor.

Correcting myself above: the transit was 9 days, not the figure I posted. Same conclusion, wrong number.

That is the ambient temperature at the destination, not the temperature inside the box. The logger measures the second one.

Yes — a logger in the box turns a fortnight of speculation into a chart.

Do you have a written baseline from before you started changing anything?

Stretched from seven days to ten to twelve over four months. Appetite told me where the limit was each time.

nobody warns you about how much of this is timing rather than dose

Correcting my own comment above: I said day three and my log says day two. Same pattern, wrong day.

Small fix — the shedding follows the rate of weight loss, not the compound, and it is temporary.

Small fix — that is the New Zealand arrangement, and the question is about Australia.

Cosigning the four-week thing. It is a minimum interval, and treating it as a schedule to keep up with is how people end up miserable at 12.5.

Yes — a logger in the box turns a fortnight of speculation into a chart.

I would separate the two claims. That the GIP arm exists is uncontroversial; that it explains your constipation pattern is a guess.

Not convinced. That is the New Zealand position and the thread is asking about Australia.

Pushback: you changed the dose, the meal timing and the training in the same fortnight, so the attribution is guesswork.

Daily rather than weekly sounds trivial until you think about what a missed dose means in each case.

the TGA shortage database is public and it is the source, not the news

Cosigning that cost and supply are legitimate reasons. Most of the stopping threads here are one of those two.

This. Decide in advance what you are watching for. Deciding in the middle of it is much harder.

That figure is from the obesity programme, and this thread is about the hepatic one.

Disagree with the panic framing. Lyophilised material tolerates ordinary transit conditions far better than these threads imply.

smaller meals, earlier, is the boring advice that works

This. Biopsy-confirmed and imaging-suggested are different evidentiary categories and get run together constantly.

daily dosing, not weekly, so the exposure profile is different

It is a dual GIP and GLP-1 receptor agonist, and the GIP arm is the part that has no equivalent in the semaglutide threads. That is why the side-effect profile reads differently rather than just milder.

switching from sema is not a dose conversion, there is no clean equivalence